IRB Number
|
# 28358
|
| Description |
This research study will evaluate
the ability of the study medication compared to placebo to reduce the need
for platelet transfusions during elective invasive procedures. |
| What is expected of me? |
Take an active pill or placebo
once daily for 14 days and come to the Hershey Medical Center for 9 visits. |
| Inclusion Criteria |
Men and women ≥ 18 yrs. old with chronic liver disease with low level of
platelets who are scheduled to have an elective invasive procedure. |
| Exclusion Criteria |
Known allergy to ingredients in study medication, portal vein thrombosis,
pregnant or nursing women. |
| Length of Study |
Approximately 2 months |
| Study Location |
Penn State Milton S. Hershey
Medical Center |
| Investigator Information |
Thomas R Riley, MD
Gastroenterology & Hepatology |
| To obtain more information about this study please contact: |
Laurie Peiffer, BS
(717) 531-8259 |
